» Articles » PMID: 14769819

Transgenic Expression of Mammalian Heparanase Uncovers Physiological Functions of Heparan Sulfate in Tissue Morphogenesis, Vascularization, and Feeding Behavior

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2004 Feb 11
PMID 14769819
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

We have generated homozygous transgenic mice (hpa-tg) overexpressing human heparanase (endo-beta-D-glucuronidase) in all tissues and characterized the involvement of the enzyme in tissue morphogenesis, vascularization, and energy metabolism. Biochemical analysis of heparan sulfate (HS) isolated from newborn mice and adult tissues revealed a profound decrease in the size of HS chains derived from hpa-tg vs. control mice. Despite this, the mice appeared normal, were fertile, and exhibited a normal life span. A significant increase in the number of implanted embryos was noted in the hpa-tg vs. control mice. Overexpression of heparanase resulted in increased levels of urinary protein and creatinine, suggesting an effect on kidney function, reflected also by electron microscopy examination of the kidney tissue. The hpa-tg mice exhibited a reduced food consumption and body weight compared with control mice. The effect of heparanase on tissue remodeling and morphogenesis was best demonstrated by the phenotype of the hpa-tg mammary glands, showing excess branching and widening of ducts associated with enhanced neovascularization and disruption of the epithelial basement membrane. The hpa-tg mice exhibited an accelerated rate of hair growth, correlated with high expression of heparanase in hair follicle keratinocytes and increased vascularization. Altogether, characterization of the hpa-tg mice emphasizes the involvement of heparanase and HS in processes such as embryonic implantation, food consumption, tissue remodeling, and vascularization.

Citing Articles

Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches.

Hamo-Giladi D, Fokra A, Sabo E, Kabala A, Minkov I, Hamoud S J Cell Mol Med. 2024; 28(17):e18512.

PMID: 39248454 PMC: 11382361. DOI: 10.1111/jcmm.18512.


Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.

Shang R, Rodrigues B J Pharm Pharm Sci. 2024; 27:13199.

PMID: 39081272 PMC: 11286490. DOI: 10.3389/jpps.2024.13199.


Loss of 3-O-sulfotransferase enzymes, Hs3st3a1 and Hs3st3b1, reduces kidney and glomerular size and disrupts glomerular architecture.

Patel V, Ball J, Choi S, Lane E, Wang Z, Aure M Matrix Biol. 2024; 133:134-149.

PMID: 38944161 PMC: 11402573. DOI: 10.1016/j.matbio.2024.06.006.


Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake.

Abecassis A, Hermano E, Yifrach A, Popovtzer A, Meirovitz A, Elkin M Front Cell Dev Biol. 2023; 11:1287084.

PMID: 38078007 PMC: 10702555. DOI: 10.3389/fcell.2023.1287084.


Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.

Vlodavsky I, Kayal Y, Hilwi M, Soboh S, Sanderson R, Ilan N Proteoglycan Res. 2023; 1(3):e6.

PMID: 37547889 PMC: 10398610. DOI: 10.1002/pgr2.6.